Contact us
Let us know about your remote blood biomarker monitoring needs.
50 Milk Street
16th floor
Boston, MA 02109
contact@generalprognostics.com
A bloodless future for healthcare?
Blood tests are the gold standard for predicting disease progression. Unfortunately, blood tests may also be time consuming, expensive, and painful. What if your smartwatch could tell you when vital blood biomarkers change?
Our Purpose
GPx is enhancing remote patient management by building a new class of biomarkers called Bloodless Blood Tests. Through our AI-powered Canary Prediction Engine, digital biomarkers collected from patient wearables and peripherals transform into an unparalleled window into patient blood biomarker status. With this data, physicians benefit from presymptomatic detection of critical patient condition changes, enabling timely treatment that avoids hospital readmissions.
Our News
Find out the latest on GPx
Thank you @hbshealthalumni and @HBSAngelsNY for the opportunity to present our vision of #bloodlessbloodtest to the judges and how GPx can help improve outcomes for patients with #cardiorenaldisease.
#cardiotwitter #heartfailure
HBSHAA and HBSAAGNY announce our APR 27th Startup Showcase - an opportunity for a select group of 6 startup finalists to tell their story to HBS angels, VCs, other investors, and advisors. Register to hear their pitches!! https://bit.ly/APRStartUpShowcaseReg #keepconnectedstaysmart @HBSHealth